Alastair Garfield - Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC.

Issuer-level insider activity

Role
Chief Scientific Officer
Issuer ticker
RYTM on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Alastair Garfield since 06 Aug 2025

Reported holdings for Alastair Garfield in RHYTHM PHARMACEUTICALS, INC.

Form 4 holding Chief Scientific Officer

RHYTHM PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
8,888
Estimated value
$1,524,913
Report date
01 Jul 2026
Price
$57.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Alastair Garfield in RHYTHM PHARMACEUTICALS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .